| 1 |
Petrikaite V, D'Avanzo N, Celia C, Fresta M. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models. Drug Resist Updat 2023;68:100956. [PMID: 36958083 DOI: 10.1016/j.drup.2023.100956] [Reference Citation Analysis]
|
| 2 |
Zhang Y, Yang X, Xu S, Jiang W, Gu Z, Guo M, Wei J. Multifunctional Dendritic Au@SPP@DOX Nanoparticles Integrating Chemotherapy and Low-Dose Radiotherapy for Enhanced Anticancer Activity. Mol Pharm 2023;20:1519-30. [PMID: 36702154 DOI: 10.1021/acs.molpharmaceut.2c00754] [Reference Citation Analysis]
|
| 3 |
Li L, Duns GJ, Dessie W, Cao Z, Ji X, Luo X. Recent advances in peptide-based therapeutic strategies for breast cancer treatment. Front Pharmacol 2023;14:1052301. [PMID: 36794282 DOI: 10.3389/fphar.2023.1052301] [Reference Citation Analysis]
|
| 4 |
Kong X, Qi Y, Wang X, Jiang R, Wang J, Fang Y, Gao J, Chu Hwang K. Nanoparticle Drug Delivery Systems and Their Applications as Targeted Therapies for Triple Negative Breast Cancer. Progress in Materials Science 2023. [DOI: 10.1016/j.pmatsci.2023.101070] [Reference Citation Analysis]
|
| 5 |
Li T, Liu Z, Fu X, Chen Y, Zhu S, Zhang J. Co-delivery of Interleukin-12 and Doxorubicin Loaded Nano-delivery System for Enhanced Immunotherapy with Polarization toward M1-type Macrophages. Eur J Pharm Biopharm 2022:S0939-6411(22)00140-0. [PMID: 35811038 DOI: 10.1016/j.ejpb.2022.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Zhang Y, Li K, Han X, Chen Q, Shao L, Bai D. A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis. Sci Rep 2022;12:10354. [PMID: 35725767 DOI: 10.1038/s41598-022-14518-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Evren Okur M, I. Siafaka P, Tutar M, Tutar Y. Recent Advancements in Apoptosis-Based Therapeutic Approaches for Cancer Targeting. Regulation and Dysfunction of Apoptosis 2022. [DOI: 10.5772/intechopen.99202] [Reference Citation Analysis]
|
| 8 |
Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Zhang C, Zhou X, Zhang H, Han X, Li B, Yang R, Zhou X. Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer. Front Pharmacol 2022;13:776895. [DOI: 10.3389/fphar.2022.776895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Omar H, Fardous R, Alhindi YM, Aodah AH, Alyami M, Alsuabeyl MS, Alghamdi WM, Alhasan AH, Almalik A. α1-Acid Glycoprotein-Decorated Hyaluronic Acid Nanoparticles for Suppressing Metastasis and Overcoming Drug Resistance Breast Cancer. Biomedicines 2022;10:414. [DOI: 10.3390/biomedicines10020414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Yang Y, Zhao Q, Peng Z, Zhou Y, Niu MM, Chen L. A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy. Front Pharmacol 2021;12:811724. [PMID: 35095524 DOI: 10.3389/fphar.2021.811724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Berillo D, Yeskendir A, Zharkinbekov Z, Raziyeva K, Saparov A. Peptide-Based Drug Delivery Systems. Medicina (Kaunas) 2021;57:1209. [PMID: 34833427 DOI: 10.3390/medicina57111209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 13 |
Xia W, Tao Z, Zhu B, Zhang W, Liu C, Chen S, Song M. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy. Int J Mol Sci 2021;22:9118. [PMID: 34502028 DOI: 10.3390/ijms22179118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 14 |
Arulkumar M, Mathivanan V, Revathi R, Wang Z. Recent Development in Peptide-Nanosystems for Combating Multidrug Resistant Cancer Cells. Nanotechnology in the Life Sciences 2021. [DOI: 10.1007/978-3-030-61021-0_7] [Reference Citation Analysis]
|
